S. Bresciani, D. O’Hagan / Tetrahedron Letters 51 (2010) 5795–5797
5797
produced when the adduct reacts with the alcohol as illustrated in
Scheme 3. A second equivalent will buffer this HF as hydrogen
bifluoride, and then the third equivalent would generate a more
nucleophilic fluoride ion.
for the minor (R)-enantiomer and tR = 42.5 min for the major (S)-
enantiomer, indicated that the optical purity was 99% ee; ½a D22
ꢂ
+117.5 (c 1.4, CDCl3); mmax (NaCl)/cmꢀ1 3083, 3062, 3027, 2972,
2937, 2877, 1761, 1714, 1448, 1350, 1091; dH (400 MHz, CDCl3)
7.51–7.36 (m, 5H), 5.80 (d, J = 47.5, 1H), 3.78 (s, 3H); dC
(75.5 MHz, CDCl3) 169.1 (d, J = 27.7, C), 134.3 (d, J = 20.6, C),
129.8 (d, J = 2.1, CH), 128.9 (CH), 126.8 (d, J = 6.1, CH), 89.4 (d,
J = 185.6, CH), 52.7 (s, CH3); dF (282 MHz, CDCl3) ꢀ180.3 (d,
J = 47.5 Hz, 1F); dF{H} (282 MHz, CDCl3) ꢀ180.3 (s, 1F); GC/MS (EI-
SIM, +ve) m/z 168 [M+]; HRMS (ESI, +ve) C9H9FO2Na+ requires
m/z 191.0484, found 191.0482.
2. Experimental procedure and physical data for (S)-8 (95% ee,
entry 14 in Table 1)
N-(Trimethylsilyl)morpholine (neat, 447
added dropwise to a solution of DAST (312
l
l, 2.49 mmol) was
l
l, 2.43 mmol) in dry
CH2Cl2 (0.96 ml) at ꢀ78 °C. The resulting solution was stirred at
rt for 2.5 h. The reaction mixture was further cooled to ꢀ78 °C
and a solution of (R)-(+)-1-phenylethanol (7) (90 ll, 0.74 mmol)
Acknowledgement
in dry CH2Cl2 (2.24 ml) was slowly added via cannula. The result-
ing solution was stirred at rt for 15 h. The mixture was then slowly
poured into 15 ml of saturated aqueous NaHCO3 solution. The or-
ganic layer was separated and the aqueous layer was extracted
with CH2Cl2 (3 ꢁ 1.5 ml). The combined organic layers were dried
over anhydrous MgSO4 and the solvent was evaporated under re-
duced pressure. The residue was purified by silica gel chromatog-
raphy (100% pentane) to afford the desired product (S)-8 (65 mg,
71% yield) as a colourless oil. Chiral-phase GC/MS (EI) analysis of
the product, tR = 20.3 min for the major (S)-enantiomer and
tR = 21.3 min for the minor (R)-enantiomer, indicated that the opti-
We thank Dr. T. Umemoto and T. Toyokura, IM&T Research,
(Denver, CO, USA) for providing a sample of Fluolead™, and one
of us (S.B.) thanks EPSRC for the studentship funding.
Supplementary data
Supplementary data associated with this article can be found, in
cal purity was 95% ee; ½a D22
ꢂ
+35.6 (c 1.0, CHCl3);
mmax (NaCl)/cmꢀ1
References and notes
3083, 3064, 3034, 2980, 2926, 1451, 1211, 1063; dH (300 MHz,
CDCl3) 7.43–7.29 (m, 5H), 5.64 (dq, J = 47.6, 6.4, 1H), 1.65 (dd,
J = 23.9, 6.4, 3H); dC (75.5 MHz, CDCl3) 141.7 (d, J = 20.0, C), 128.6
(CH), 128.3 (d, J = 1.9, CH), 125.3 (d, J = 6.7, CH), 91.1 (d, J = 167.4,
CH), 23.1 (d, J = 25.3, CH3); dF (282 MHz, CDCl3) ꢀ167.5 (dq,
J = 47.6, 23.9, 1F); dF{H} (282 MHz, CDCl3) ꢀ167.5 (s, 1F); GC/MS
(EI, +ve) m/z 109, 124 [M+]; HRMS (EI, +ve) C8H9F requires m/z
124.0688, found 124.0689.
1. (a) Müller, K.; Boehm, H.-J. Chem. Biol. 2009, 16, 1130–1131; (b) Morgenthaler,
M.; Schweizer, E.; Hoffman-Röder, A.; Benini, F.; Martin, R. E.; Jaeschkee, G.;
Wagner, B.; Fischer, H.; Bendels, S.; Zimmerl, D.; Schneider, J.; Diederich, F.;
Kansy, M.; Müller, K. ChemMedChem. 2007, 2, 1100–1115; (c) Olsen, J.; Seiler,
P.; Wagner, B.; Fischer, H.; Tschopp, T.; Obst-Sander, U.; Banner, D. W.; Kansy,
M.; Müller, K.; Diederich, F. Org. Biomol. Chem. 2004, 2, 1339–1352.
2. O’Hagan, D. Chem. Soc. Rev. 2008, 37, 308–319.
3. Sparr, C.; Schweizer, W. B.; Senn, H. M.; Gilmour, R. Angew. Chem., Int. Ed. 2009,
48, 3065–3068.
4. (a) Haggmann, W. K. J. Med. Chem. 2008, 51, 4359–4369; (b) O’Hagan, D. J.
Fluorine Chem. 2010, in press; (c) Purser, S.; Moore, P. R.; Swallow, S.;
Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320–330.
3. Experimental procedure and physical data for (S)-10 (99% ee,
5. Brunet, V.; O’Hagan, D. Angew. Chem., Int. Ed. 2008, 47, 1179–1182.
6. (a) Enders, D.; Huettle, M. R. M. Synlett 2005, 991–993; (b) Marigo, M.;
Fielenbach, D.; Braunton, A.; Kjærsaard, A.; Jørgenson, K. A. Angew. Chem., Int.
Ed. 2005, 44, 3703–3706; (c) Steiner, D. D.; Mase, N.; Barbas, C. F., III Angew.
Chem., Int. Ed. 2005, 44, 3706–3710; (d) Beeson, T. D.; McMillan, D. W. C. J. Am.
Chem. Soc. 2005, 127, 8826–8828.
7. (a) Reddy, D. S.; Shibata, N.; Nagai, J.; Nakamura, S.; Toru, T.; Kanemasa, S.
Angew. Chem., Int. Ed. 2008, 47, 164–168; (b) Moriya, K. I.; Hamashima, Y.;
Sodeoka, M. Synlett 2007, 1139–1142; (c) Suzuki, T.; Goto, T.; Hamashima, Y. J.
Org. Chem. 2007, 72, 246–250; (d) Cahard, D.; Audouard, C.; Plaquevent, J. C.;
Roques, N. Org. Lett. 2000, 2, 3699–3701; (e) Shibata, N.; Suzuki, E.; Takeuchi, Y.
J. Am. Chem. Soc. 2000, 122, 10728–10729; (f) Hintermann, L.; Togni, A. Angew.
Chem., Int. Ed. 2000, 39, 4342–4359.
8. Middleton, W. J. J. Org. Chem. 1975, 40, 574–578.
9. Lal, G. S.; Pez, G. P.; Pesaresi, R. J.; Prozonic, F. M.; Cheng, H. J. Org. Chem. 1999,
64, 7048–7054.
10. (a) Umemoto, T.; Xu, Y. U.S. Patent 7,265,247 (IM&T Research Inc.); Chem. Abstr.
2007, 147, 322721; (b) Umemoto, T.; Singh, R. P. U.S. Patent 20080039660
(IM&T Research Inc.) Feb 2008; Chem. Abstr. 2008, 148, 239352; (c) Bresciani, S.
J. Fluorine Chem. 2009, 130, 537–543.
11. Bio, M. M.; Waters, M.; Javadi, G.; Song, Z. J.; Zhang, F.; Thomas, D. Synthesis
2008, 891–896.
entry 7 in Table 2)
N-(Trimethylsilyl)morpholine (neat, 298
added dropwise to a solution of Deoxo-Fluor™ (50% in THF,
690
l, 1.62 mmol) in dry CH2Cl2 (2.20 ml) at ꢀ78 °C. The resulting
ll, 1.66 mmol) was
l
solution was stirred at rt for 2.5 h. The reaction mixture was fur-
ther cooled to ꢀ78 °C and a solution of methyl (R)-(ꢀ)-mandelate
(9) (248 mg, 1.48 mmol) in dry CH2Cl2 (4.48 ml) was slowly added
via cannula. The resulting solution was stirred at rt for 24 h. The
mixture was then slowly poured into 30 ml of saturated aqueous
NaHCO3 solution. The organic layer was separated and the aqueous
layer was extracted with CH2Cl2 (3 ꢁ 3.0 ml). The combined organ-
ic layers were dried over anhydrous MgSO4 and the solvent was
evaporated under reduced pressure. The residue was purified by
silica gel chromatography (9:1 hexane:EtOAc?4:1) to afford the
desired product (S)-10 (48 mg, 19% yield) as a colourless oil. Chi-
ral-phase GC/MS (EI-SIM) analysis of the product, tR = 42.2 min